|
- Clinical Laboratory Improvement Amendments (CLIA) | CMS
The Centers for Medicare Medicaid Services (CMS) regulates all laboratory testing (except research) performed on humans in the U S through the Clinical Laboratory Improvement Amendments (CLIA) program
- Home | Cruise Lines International Association
CLIA unites the global cruise industry by providing a strong collective voice for cruise lines, valuable connections and insights for Executive Partners, and training, resources, and support for the travel trade community
- Clinical Laboratory Improvement Amendments | Clinical Laboratory . . .
The Clinical Laboratory Improvement Amendments of 1988 (CLIA) regulations include federal standards applicable to all U S facilities or sites that test human specimens for health assessment or to diagnose, prevent, or treat disease
- How to Apply for a CLIA Certificate, Including International . . .
Under CLIA, a facility is a laboratory if it performs even one test on “materials derived from the human body for the purpose of providing information for the diagnosis, prevention or treatment of any disease or impairment of, or the assessment of the health of, human beings ”
- CLIA Regulations and Federal Register Documents | CMS
The most current version of the CLIA regulations Part 493, including all changes through 5 12 14 This information is on the Centers for Disease Control and Prevention (CDC) website; The Federal Register search feature at the GPO Access Site
- CMS’s CLIA Rule Now Fully in Effect - ascp. org
On December 28, 2024, the Centers for Medicare Medicaid Services’ (CMS) final rule updating the Clinical Laboratory Improvement Amendments regulations went fully into effect
- Test Complexities | Clinical Laboratory Improvement Amendments (CLIA) | CDC
Clinical laboratory test systems are assigned a moderate or high complexity category on the basis of seven criteria given in the CLIA regulations For commercially available FDA-cleared or approved tests, FDA scores the tests using these criteria during the pre-market approval process
- CLIA | HHS. gov
The final rule amends the Clinical Laboratory Improvement Amendments of 1988 (CLIA) regulations to allow laboratories to give a patient, or a person designated by the patient, his or her “personal representative,” access to the patient’s completed test reports on the patient’s or patient’s personal representative’s request
|
|
|